Learn More
Medchemexpress LLC (4S)-GLP-1 receptor agonist 14 | 2758659-09-3 | 99.6% | 880.94 | 5 MG

Supplier: Medchemexpress LLC HY1647745MG
(4S)-GLP-1 receptor agonist 14 is a potent and orally active GLP-1 receptor agonist with an EC50 ≤ 20 nM. It is intended for research applications related to diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, and nonalcoholic steatohepatitis (NASH), as well as other conditions associated with the GLP-1 receptor. In vitro, it inhibits OATP1B1 with an IC50 < 1 μM in HEK293 cells. In vivo, a single oral dose at 5 mg/kg in rats demonstrates good pharmacokinetic parameters, with a Cmax of 1700 ng/mL, AUC of 10193 ng·h/mL, and an oral bioavailability (F) of 90%.
- Potent and orally active GLP-1 receptor agonist
- EC50 ≤ 20 nM
- Inhibits OATP1B1 with an IC50 < 1 μM in HEK293 cells
- Exhibits good pharmacokinetic parameters in rats
- Suitable for research on diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, and nonalcoholic steatohepatitis (NASH)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.